Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma

A relevant fraction of castration-resistant prostate cancers (CRPC) evolve into fatal neuroendocrine (NEPC) tumors in resistance to androgen deprivation and/or inhibitors of androgen receptor pathway. Therefore, effective drugs against both CRPC and NEPC are needed. We have previously described a du...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Immunol
Hlavní autoři: Sulsenti, Roberta, Frossi, Barbara, Bongiovanni, Lucia, Cancila, Valeria, Ostano, Paola, Fischetti, Irene, Enriquez, Claudia, Guana, Francesca, Chiorino, Giovanna, Tripodo, Claudio, Pucillo, Carlo E., Colombo, Mario P., Jachetti, Elena
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2021
Témata:
Immunology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7960782/
https://ncbi.nlm.nih.gov/pubmed/33737929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.622001
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky